Page last updated: 2024-08-22

ethamsylate and 6-ketoprostaglandin f1 alpha

ethamsylate has been researched along with 6-ketoprostaglandin f1 alpha in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cooke, RW; Doyle, J; Rennie, JM	1

Trials

1 trial(s) available for ethamsylate and 6-ketoprostaglandin f1 alpha

Article	Year
Ethamsylate reduces immunoreactive prostacyclin metabolite in low birthweight infants with respiratory distress syndrome. Early human development, 1986, Volume: 14, Issue:3-4 Topics: 6-Ketoprostaglandin F1 alpha; Benzenesulfonates; Cerebral Hemorrhage; Clinical Trials as Topic; Double-Blind Method; Ethamsylate; Humans; Infant, Low Birth Weight; Infant, Newborn; Respiratory Distress Syndrome, Newborn	1986

Article

Year

Ethamsylate reduces immunoreactive prostacyclin metabolite in low birthweight infants with respiratory distress syndrome.

Early human development, 1986, Volume: 14, Issue:3-4

Topics: 6-Ketoprostaglandin F1 alpha; Benzenesulfonates; Cerebral Hemorrhage; Clinical Trials as Topic; Double-Blind Method; Ethamsylate; Humans; Infant, Low Birth Weight; Infant, Newborn; Respiratory Distress Syndrome, Newborn

1986